COCP Cocrystal Pharma, Inc.
Healthcare$1.13-1.74%ClosedMarket Cap: $11.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.85
P/S
52.39
EV/EBITDA
-0.99
DCF Value
$0.47
FCF Yield
-66.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
669.8%
Operating Margin
-4015.1%
Net Margin
-3924.0%
ROE
-150.6%
ROA
-118.9%
ROIC
-163.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $225.0K | 59.6% | $-2.4M | $-2.3M | $— | — |
| Q4 null | $0.00 | Infinity% | $-2.5M | $-2.4M | $— | — |
| FY null | $0.00 | NaN% | $-9.0M | $-8.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.1M | $-2.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.1M | $-2.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.3M | $-2.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.2M | $-3.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-17.9M | $-17.5M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-5.0M | $-4.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-5.4M | $-5.3M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-4.2M | $-4.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-4.7M | $-4.5M | $-0.44 | — |